Loading clinical trials...
Loading clinical trials...
The Caris Biorepository Research Protocol
The Biorepository for Caris Life Sciences is designed for the purpose of making quality biospecimens and associated clinical data available for research studies related to advancing precision medicine and improving care for patients. The Caris Biorepository is a repository of prospectively collected biological specimens and associated clinical and demographic data gathered from multiple sources to be stored, used and shared for research. Caris Life Sciences will maintain the data and specimens and will control access to and use of the information and specimens by multiple individuals for multiple purposes which may evolve over time.
The Caris Biorepository is an effort toward defining the future of medicine incorporating the discoveries of the genomic era by providing physicians, researchers and scientists access to quality human specimens and data aimed at improving human health and fighting disease. This will be accomplished through acquiring and sharing valuable biospecimen information and clinical outcomes in a collaborative, secure environment. The Caris Biorepository will bridge the gap and correlate human specimens with clinical and specimen data valuable to multiple and varying entities interested in advancing science with precision medicine by targeting disease treatments. The objective of this project is to develop and implement a state-of-the-science Biorepository that ensures molecular integrity and clinical relevance of human biospecimens used in research and clinical medicine. The Caris Biorepository will also provide vital biospecimens and data to internal researchers and external research collaborators such as government, academia and industry collaborators for the use of drug development discoveries, clinically relevant research trials, publications and posters, and the implementation of future healthcare policies. This project may also impact characterization of trends in practice patterns and their relation to patient outcomes as well as the economic implications of differing evaluation, treatment and management paradigms.
Age
18 - No limit years
Sex
ALL
Healthy Volunteers
Yes
University of South Alabama
Mobile, Alabama, United States
Southwest Medical Imaging
Scottsdale, Arizona, United States
St. Bernards Medical Center
Jonesboro, Arkansas, United States
CARTI Cancer Center
Little Rock, Arkansas, United States
ObjectiveHealth - ARcare Center for Clinical Research
Little Rock, Arkansas, United States
Lee Memorial Health System
Fort Myers, Florida, United States
Cancer Care of North Florida
Lake City, Florida, United States
Advent Health
Orlando, Florida, United States
The University of South Florida
Tampa, Florida, United States
Cleveland Clinic Florida
Weston, Florida, United States
Start Date
November 1, 2010
Primary Completion Date
November 1, 2030
Completion Date
November 1, 2035
Last Updated
January 21, 2026
100,000
ESTIMATED participants
Lead Sponsor
Caris Science, Inc.
NCT06498635
NCT00026884
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions